Sphingolipids in atherosclerosis and vascular biology

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 10, 1998, Pages 1523-1533

  Chatterjee, Subroto ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cell proliferation; Lipoproteins; Neutral sphingomyelinase; Signal transduction

Indexed keywords

GLYCOSPHINGOLIPID; LACTOSYLCERAMIDE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; SPHINGOLIPID; SPHINGOMYELIN PHOSPHODIESTERASE; SUPEROXIDE;

APOPTOSIS; ATHEROSCLEROSIS; CELL PROLIFERATION; DISEASE ASSOCIATION; GENE EXPRESSION; LIPID METABOLISM; LIPID OXIDATION; LIPOGENESIS; ONCOGENE C FOS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0031694479     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.10.1523     Document Type: Review

References (16)

1. Thudichum JLW. Reports of the Medical Officer of Privy Council and Local Government Board. 1876;N serial No. VIII, 117; 1874;N serial No. III, 113.
2. Desnick R, Ioannou YA, Eng CM. α-Galactodase deficiency in Fabry's disease. In: Scriver CR, Beaudet Al, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Diseases. New York, NY: McGraw-Hill Inc; 1995;II:2484.
3. Miyake M, Hakomori S. A specific surface glycoconjugate controlling cell motility: evidence by functional monoclonal antibodies that inhibit cell motility and tumor metastasis. Biochemistry. 1991;30:3328-3334.
4. Hannun YA. The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem. 1994;269:3125-3128.
5. Spiegel S, Merrill A. Sphingolipid metabolism and cell growth regulation. FASEB J. 1996;10:1388-1397.
6. Pena LA, Fuks Z, Kolesnick R. Stress-induced apoptosis and the sphingomyelin pathway. Biochem Pharmacol. 1997;53:615-621.
7. Shayman JA. Sphingolipids: their role in intracellular signaling and renal growth. J Am Soc Nephrol. 1996;7:171-182.
8. Merril AH Jr, Jones DD. An update of the enzymology and regulation of sphingomyelin metabolism. Biochim Biophys Acta. 1990;1044:1-12.
9. Radin NS. Biosynthesis of the sphingoid bases: a provation. J Lipid Res. 1984;25:1536-1540.
10. Obeid L, Linardic CM, Kerolac LA, Hannun Y. Programmed cell death induced by ceramide. Science. 1992;259:1769-1771.
11. Basu S, Basu M. Biosynthesis and regulation of glycosphingolipids. In: Pinto BM, Pastgheits S, Harves JW, eds. Comprehensive Natural Products Chemistry - Carbohydrate. New York, NY: Pergamon Press; 1997.
12. Chaiterjee S, Sekerke CS, Kwiterovich PO Jr. Increased urinary excretion of glycosphingolipids in familial hypercholesterolemia. J Lipid Res. 1982;23:513-522.
13. Chatterjee S, Dey S, Shi W-Y, Thomas K, Hutchins GM. Accumulation of glycosphingolipids in human atherosclerotic plaque and unaffected aorta tissue. Glycobiology. 1997;7:57-65.
14. Mukhin D, Chao F-F, Kruth HS. Glycosphingolipid accumulation in the aortic wall is another feature of human atherosclerosis. Arterioscler Thromb Vasc Biol. 1995;15:1607-1615.
15. Beutler E, Grabowski G. Gaucher's disease. In: Scriver CR, Beaudet Al, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Diseases. New York, NY: McGraw-Hill Inc; 1995;II:2601-2624.
16. Moser HW. Ceramide deficiency: Farber's disease lipogranulomatosis in the metabolic and molecular basis of inherited disease. In: Scriver CR, Beaudet Al, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Diseases. New York, NY: McGraw-Hill Inc; 1994;II: 2589-2599.